UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
| (Exact name of registrant as specified in its charter) |
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including
area code: (
| Not Applicable |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
On November 17, 2026, a subsidiary of Planet Green Holdings Corp. (“Planet Green” or the “Company”), Hubei Taihe Biotechnology Co., Ltd. (“Taihe Bio”), entered into a technology transfer agreement (the “Transfer Agreement”) with Harbin Aikesailun Biotechnology Co., Ltd. (“Aikesailun Bio”) to acquire a registered immune-support health food product: Aikesailun-branded bovine colostrum, vitamin C and lactoferrin chewable tablets (the “Product”). Under the Transfer Agreement, Taihe Bio will acquire the Product’s proprietary formulation, production process, quality standards and related technical know-how, together with the associated health food registration certificate rights in China. Taihe Bio agreed to pay an amount of RMB1,550,000 (US$232,500) to Aikesailun Bio in consideration for its acquisition of the Product,
In addition, Taihe Bio is responsible for certain transfer-related costs, including notarization, sample production and testing. Aikesailun Bio will provide technical materials and assistance with the transfer and registration process. The Transfer Agreement also contains provisions regarding payment suspension, delays and termination.
The foregoing description is qualified in its entirety by reference to the Transfer Agreement, which is filed as Exhibit 10.1 to this Current Report and incorporated herein by reference.
Item 8.01 Other Events.
On November 17, 2026, the Company issued a press release announcing that it had entered into the Transfer Agreement. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. |
| Exhibit No. | Description | |
| 10.1 | Technology Transfer Agreement, dated November 17, 2026, by and between Hubei Taihe Biotechnology Co., Ltd. and Harbin Aikesailun Biotechnology Co., Ltd. | |
| 99.1 | Press Release dated November 17, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| Dated: November 18, 2026 | PLANET GREEN HOLDINGS CORP. | |
| By: | /s/ Bin Zhou | |
| Name: | Bin Zhou | |
| Title: | Chief Executive Officer and Chairman | |
2